Freenome Raises $300M In Series D Financing To Advance Multiomics Platform For Early Cancer Detection
Dec 07, 2021•over 3 years ago
Amount Raised
$300 Million
Round Type
series d
Description
Freenome, a privately held biotech company, today announced a Series D funding of $300 million. This brings the company's total financing to over $800 million since the company was founded in 2014.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech